Cigna Group stock stands 0.43 percent below its 52-week high

Published on 10/19/2026 at 09:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Target raised to USD 370.00 by Piper Sandler on October 2, 2026. Cigna Group stock costs EUR 269.05 on October 19, 2026, 0.30 percent over Xetra close.

Targets and earnings shape context

Piper Sandler raised its Cigna target from USD 346.00 to USD 370.00 on October 2, 2026.
Cigna reported USD 71.56 billion in revenue for the second quarter of 2026 against USD 70.14 billion expected.
Cigna Group stock trades at EUR 269.05 at 9:35 a.m. CEST at Lang & Schwarz on October 19, 2026, 0.30 percent above the Xetra close of October 16, 2026.

Draufsicht-Arrangement mit Aktienzertifikat, Krankenversicherungspolice, Stethoskop und Medikamentenfläschchen — Cigna Group Flatlay mit Aktienzertifikat ISIN US1255231003, Stethoskop, Versicherungspolice und Medikamentenfläschchen auf weißem Untergrund, Illustration mit AI erstellt.

The Cigna Group (ISIN US1255231003) was trading at EUR 269.05 at Lang & Schwarz on October 19, 2026, 0.30 percent above the Xetra close of October 16, 2026 at EUR 268.25. The stock is also 0.43 percent below its 52-week high of EUR 270.20, making the yearly peak the immediate reference point for investors.

The latest independently reported market context is a higher Piper Sandler valuation. Markets Insider reported on October 2, 2026 that Piper Sandler raised its target from USD 346.00 to USD 370.00 and retained an Overweight rating. The target change puts long-term earnings execution at the center of the valuation discussion.

Stock stays near yearly high

The price picture is supported by a relatively strong recent earnings comparison. Cigna reported adjusted earnings per share of USD 7.78 for the second quarter of 2026, above the USD 7.60 consensus estimate, while revenue reached USD 71.56 billion versus USD 70.14 billion expected. Revenue increased 6.70 percent from the prior-year quarter, according to MarketBeat on October 17, 2026.

What does the target imply?

Piper Sandler's report also cited a long-term adjusted earnings-per-share growth range of 10.00 percent to 14.00 percent and a 2030 adjusted earnings-per-share floor of USD 45.00. Those figures describe the valuation case, while the latest quarter supplies the nearer-term test.

Three dated signals

On July 30, 2026, Cigna reported USD 7.78 adjusted earnings per share and USD 71.56 billion in quarterly revenue, according to MarketBeat. On October 2, 2026, Piper Sandler lifted its target from USD 346.00 to USD 370.00, as Markets Insider reported. On October 17, 2026, MarketBeat reported that Assenagon increased its Cigna stake by 240.90 percent in the third quarter, adding 249,724 shares.

Trading dates and quote

The next dated company event identified in the reviewed company material is the October 6, 2026 launch of Health Sense, a Cigna Healthcare service connecting guidance, benefits and clinical support. The company also listed an exclusive agreement with UnitedHealthcare Global dated September 29, 2026, according to Cigna Healthcare.

Valuation remains the key question

The current euro quote leaves Cigna close to its yearly high, while the USD 370.00 target and the second-quarter revenue comparison provide the main reference points for assessing whether earnings growth can support the valuation. Cigna Group stock was trading at EUR 269.05 at Lang & Schwarz on October 19, 2026 at 9:35 a.m. CEST, 0.30 percent above the Xetra close of October 16, 2026 at EUR 268.25. The further course of trading is shown by the continuously updated real-time quote of Cigna Group stock.